- The combination of levodopa / carbidopa / entacapone in the treatment of patients with advanced Parkinson's disease2017 | First Faculty of Medicine
- Treatment of Parkinson's disease with levodopa in continuous enteral infusion2015 | First Faculty of Medicine
- Continuous intestinal levodopa infusion in patients with advanced Parkinsons disease2016 | Faculty of Medicine in Hradec Králové
- Rasagiline as an adjunct to levodopa in patients with Parkinson´s disease and motor fluctuations (LARGO)2005 | First Faculty of Medicine
- Levodopa increases functional connectivity in the cerebellum and brainstem in Parkinson's disease2013 | First Faculty of Medicine
- Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson's disease2020 | First Faculty of Medicine
- Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's Disease2019 | First Faculty of Medicine, Central Library of Charles University
- Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study2021 | First Faculty of Medicine
- Levodopa a progrese Parkinsonovy nemoci2005 | First Faculty of Medicine
- Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry2017 | First Faculty of Medicine
- Silly Walks in Parkinson's Disease: Unusual Presentation of Dopaminergic-Induced Dyskinesias2011 | First Faculty of Medicine
- Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease2018 | First Faculty of Medicine
- Restless legs syndrome- the state of the art in treatment2007 | First Faculty of Medicine
- Hemiparkinsonism and Levodopa-induced dyskinesias after focal nigral lesion2005 | First Faculty of Medicine
- Hemiparkinsonism and Levodopa-induced dyskinesias after focal nigral lesion2005 | Faculty of Physical Education and Sport
- Reply: Hemiparkinsonism and levodopa- induced dyskinesias following focal nigral lesion2006 | First Faculty of Medicine
- Hemiparkinsonism and levodopa induced dyskinesias folowing focal nigral lesion resolved after VIM thalamotomyPublication without faculty affiliation
- Comparison of dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of disease progression with dopamine transporter SPECTPublication without faculty affiliation
- Is the progression rate in Parkinson's disease patients treated with alfa-Dihydroergocryptine monotherapy different from those treated with Levodopa monotherapyPublication without faculty affiliation
- Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123 I]IPT SPECT2004 | First Faculty of Medicine
- Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123 I]IPT SPECT2004 | Faculty of Physical Education and Sport
- Progressive supranuclear palsy2020 | First Faculty of Medicine
- "Silly Walks" in Parkinson's Disease: Unusual Presentation of Dopaminergic-Induced Dyskinesias2011 | Second Faculty of Medicine
- Nejlepší postup v terapii motoricky pokročilé Parkinsonovy nemoci je intraduodenální levodopa, apomorfinová infuze nebo DBS?2018 | First Faculty of Medicine
- Advances in the treatment of Parkinson's disease2007 | First Faculty of Medicine
- Defining Speech Subtypes in De Novo Parkinson Disease Response to Long-term Levodopa Therapy2021 | First Faculty of Medicine
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: long-term results from COSMOS2023 | First Faculty of Medicine
- Dopamine agonists treatment in Parkinson's disease: experience with Pergolide2000 | First Faculty of Medicine
- Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease2022 | First Faculty of Medicine
- Cutaneous silent periods in multiple system atrophy2015 | First Faculty of Medicine, Third Faculty of Medicine